Core Viewpoint - The article highlights the internationalization and growth of Chutian Technology, a leading company in the biopharmaceutical equipment sector, showcasing its ambition to expand globally while maintaining strong local roots in Ningxiang, Hunan province [1][10]. Company Overview - Chutian Technology hosted an international conference in late June, attended by over 130 pharmaceutical executives from nearly 30 countries, emphasizing its role as a "chain leader" in the biopharmaceutical industry [1][3]. - The company has evolved from a small startup in a dilapidated barn to a global player with thousands of employees and a comprehensive range of products and services in pharmaceutical equipment [2][4][10]. Internationalization Efforts - Chutian Technology aims to enhance its international market presence and has made adjustments in response to a slowing demand in the pharmaceutical equipment industry, focusing on optimizing product solutions and increasing production efficiency [6][10]. - The company has successfully developed a complete skincare and daily chemical solution, contributing to the establishment of a smart factory for a beauty brand, showcasing its capabilities in digital transformation [7]. Local Economic Impact - Chutian Technology is recognized as a benchmark enterprise in the biopharmaceutical and life sciences sector in Ningxiang, which is being cultivated as a key emerging industry by local government [8][9]. - The local government has implemented various measures to support the development of the biopharmaceutical industry, including a framework agreement with Chutian Technology to promote collaboration [9]. Future Goals - The leadership at Chutian Technology is focused on advancing its global strategy, enhancing international competitiveness, and continuing to innovate in response to customer needs [10][11].

Core Viewpoint - Jiangnan Chemical's subsidiary, Hubei Jiangnan Chutian Technology, has been established, reflecting the company's strategic alignment with national policies and collaborative development goals [1] Company Summary - Jiangnan Chutian was registered on August 13, with Jiangnan Chemical and its wholly-owned subsidiary, Northern Explosive Technology, holding a combined 51% stake, making them the controlling shareholders [1] - Hubei Chutian Chemical holds a 49% stake in Jiangnan Chutian, indicating a partnership structure [1] - The establishment of Jiangnan Chutian is seen as a response to the Ministry of Industry and Information Technology's encouragement for the restructuring and integration of civil explosive enterprises across regions and ownership types [1] Industry Summary - The formation of Jiangnan Chutian represents a practical implementation of the national strategy for deepening collaboration between central and local governments [1] - The initiative aims to leverage complementary advantages among stakeholders and pursue a common future, highlighting a strategic layout in the industry [1]

Group 1 - The company focuses on providing automated and intelligent overall solutions for global pharmaceutical clients [2] - The relevant business and technical information will be disclosed in detail in the regular reports [2] - Company announcements will serve as the official source of information [2]

Group 1 - The company, Chutian Technology (300358), responded to investor inquiries on August 14, indicating that its business and technical conditions are detailed in regular reports and should be referenced in company announcements [1]

Core Viewpoint - Chutian Technology (300358) emphasizes its commitment to continuous improvement in operational management and enhancing various performance indicators to provide better returns for shareholders and investors [1] Summary by Relevant Categories Company Management - The company is focused on maintaining effective operational management practices [1] - There is a commitment to improving performance metrics to benefit shareholders and investors [1]

据楚天科技（300358）消息，楚天科技旗下楚天派特专注于多肽合成设备的研发与生产，为多家用户打 造的20L等不同规模的多肽设备近日完成工厂验收测试，并已发往用户现场。这些设备采用模块化设 计，符合GMP安全标准，具有良好的防腐性能和自动出料功能，提升了生产效率与安全性。楚天派特 的多肽设备以技术创新为核心，为多肽药物的研发与生产提供高效可靠的解决方案。 ...

Core Insights - Chutian Technology is transforming from manufacturing to intelligent manufacturing in the pharmaceutical equipment sector, showcasing its capabilities at the 2025 headquarters factory open day event attended by over 130 pharmaceutical leaders from nearly 30 countries [1] Group 1: Company Overview - Chutian Technology focuses on pharmaceutical equipment and has over ten subsidiaries, including Romaco Holding GmbH and Chutian Microsphere Biotechnology, enabling it to provide comprehensive solutions from laboratory research to commercial production [2] - The company has developed a "smart pharmaceutical factory" ecosystem, emphasizing the importance of key consumables in the innovative drug development process [2][3] Group 2: Product and Technology - Chutian Technology's products include high-tech disposable bioreactor bags for cell culture, which utilize a proprietary 11-layer biocomposite membrane, offering superior physical properties compared to imported alternatives [2] - The company specializes in chromatography media technology, with products certified by the US FDA, supporting the purification of biopharmaceuticals [3] Group 3: Industry Trends - The Chinese regulatory environment is evolving, with new guidelines promoting high-quality development in sterile drug production, driving demand for modular and flexible pharmaceutical equipment [3] - The trend towards small-batch production of diverse drugs is pushing the industry towards more intelligent and higher-specification equipment [3] Group 4: Global Strategy - Chutian Technology aims to become a global leader in pharmaceutical equipment by leveraging its acquisition of Romaco to enhance its international presence [6] - The company has exported products to over 40 countries and regions, with new domestic export orders exceeding 1.2 billion yuan in 2024, marking a significant entry into high-end markets [6] Group 5: Operational Excellence - The company employs digital technologies such as SCADA, MES, and digital twin technology to enhance product traceability and real-time monitoring throughout the production process [4] - Chutian Technology has established a dual-headquarters model, with its headquarters in Changsha focusing on basic research and Romaco in Germany serving the European and American markets, creating a synergistic operational framework [7] Group 6: Future Goals - The company aims to become a leading global pharmaceutical equipment group by 2030, enhancing its international competitiveness and brand influence in the pharmaceutical sector [7]

Core Viewpoint - The article highlights the dedication and innovation of young workers in precision machining, exemplified by Huang Zhongqin, who has become a key technical talent at Chutian Technology through hard work and creativity [1][4]. Group 1: Individual Achievement - Huang Zhongqin, a young craftsman from Huaihua, has excelled in the precision machining field, overcoming challenges and achieving a high technical level in just four years, which typically takes ten years [4][7]. - He won a provincial second prize in a skills competition while studying at Zhangjiajie Aviation Vocational Technical College, which led to his recruitment by Chutian Technology [4]. Group 2: Innovation and Collaboration - Huang faced difficulties with a special connecting rod that repeatedly failed due to stress deformation, prompting him to innovate by creating a new bonding method and refining the process [4][6]. - He promotes a culture of knowledge sharing in the workplace, combining technical skills learned in school with practical experience from senior workers, fostering a collaborative environment [4][6]. Group 3: Industry Environment - The article emphasizes the supportive industrial ecosystem in Changsha, which nurtures talent and innovation in smart manufacturing, attracting young professionals like Huang [7]. - Huang expresses a strong commitment to contributing to the future of the industry and embodies the spirit of craftsmanship, which is crucial for the development of precision manufacturing [7].

| 证券代码：300358 | 证券简称：楚天科技 | 公告编号：2025-044 | 号 | | --- | --- | --- | --- | | 债券代码：123240 | 债券简称：楚天转债 | | | 楚天科技股份有限公司 关于 2025 年第二季度可转换公司债券转股情况的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、楚天转债（债券代码：123240）转股期限为 2024 年 8 月 6 日至 2030 年 1 月 30 日，最新有效的转股价格为人民币 8.00 元/股。 2、2025 年第二季度，共有 0 张"楚天转债"完成转股（票面金额 0 元人民 币），转换成"楚天科技"股票 0 股。 3、截至 2025 年第二季度末，楚天科技股份有限公司（以下简称"公司"） 剩余可转换公司债券（以下简称"可转债"）为 9,999,810 张，剩余票面总金额 为 99,998.10 万元人民币。 根据《深圳证券交易所创业板股票上市规则》和《深圳证券交易所上市公司 自律监管指引第 15 号——可转换公司债券》的有关规定，公司现将 2025 ...

| 证券代码：300358 | 证券简称：楚天科技 | 公告编号：2025-043 | 号 | | --- | --- | --- | --- | | 债券代码：123240 | 债券简称：楚天转债 | | | 楚天科技股份有限公司 关于完成工商变更登记并换发营业执照的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 目前，公司已完成相关工商变更登记、章程备案等手续，并取得了长沙市市场 监督管理局换发的《营业执照》，变更登记后的公司基本情况如下： 一、基本登记信息 1、统一社会信用代码：91430100743176293C 5、法定代表人：唐岳 许可项目：电气安装服务；特种设备安装改造修理；特种设备设计；建设工程 施工；第二类医疗器械生产；消毒器械生产；消毒器械销售；特种设备制造。(依 2、名称：楚天科技股份有限公司 3、类型：股份有限公司（上市、自然人投资或控股） 4、住所：宁乡市玉潭镇新康路 1 号 楚天科技股份有限公司（以下简称"公司"）于 2025 年 4 月 26 日召开第五届 董事会第三十四次会议，审议通过了《关于变更注册资本暨修订<公司章程> ...